Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
Australia
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. 5,5-diphenylhydantoin
2. 5,5-diphenylimidazolidine-2,4-dione
3. Antisacer
4. Difenin
5. Dihydan
6. Dilantin
7. Diphenylhydantoin
8. Diphenylhydantoinate, Sodium
9. Epamin
10. Epanutin
11. Fenitoin
12. Hydantol
13. Phenhydan
14. Phenytoin
15. Sodium Diphenylhydantoinate
1. 630-93-3
2. 5,5-diphenylhydantoin Sodium Salt
3. Dilantin Sodium
4. Diphenylhydantoin Sodium
5. Diphantoine
6. Tacosal
7. Antisacer
8. Phenytoin Sodium Salt
9. Diphentoin
10. Epanutin
11. Solantoin
12. Solantyl
13. Eptoin
14. Sodium Phenytoin
15. Diphenylan Sodium
16. Sodium 2,5-dioxo-4,4-diphenylimidazolidin-1-ide
17. Phenytek
18. Sodium Diphenylhydantoin
19. 5,5-diphenylhydantoin Sodium
20. Mls000554076
21. 2,4-imidazolidinedione, 5,5-diphenyl-, Monosodium Salt
22. 4182431bjh
23. Citrullamon
24. Fenidantoin
25. Novodiphenyl
26. Aladdin
27. Alepsin
28. Cumatil
29. Decatona
30. Dihydan
31. Ditomed
32. Enkefal
33. Epdantoin
34. Epileptin
35. Epsolin
36. Eptolin
37. Fenigramon
38. Fenitron
39. Fenytoin
40. Hidantin
41. Phenilep
42. Smr000146393
43. Ditoin
44. Episar
45. Muldis
46. Fenitoin Sodium
47. Hidantal Sodium
48. Lepitoin Sodium
49. Denyl Sodium
50. Aleviatin Sodium
51. Diphenine Sodium
52. Epilantin-e
53. Fenitoina Sodica
54. Soluble Phenytoin
55. Dilantin Infatabs
56. Metinal Idantoina
57. Di-len
58. Dilantin Injection
59. Dilantin Suspension
60. Om-hydantoine Sodium
61. Sdph
62. Prompt Phenytoin Sodium
63. Sodium;5,5-diphenylimidazolidin-3-ide-2,4-dione
64. Mls000028562
65. Sodium Diphenyl Hydantoinate
66. Diphenylhydantoin Sodium Salt
67. Sodium 5,5-diphenylhydantoinate
68. Phenytoin, Sodium Salt
69. Sodium 5,5-diphenyl Hydantoinate
70. Nsc-757274
71. Extended Phenytoin Sodium
72. Smr000058987
73. Einecs 211-148-2
74. Mfcd00069674
75. Hydantoin, 5,5-diphenyl-, Sodium Salt
76. Phenytoin Sodium [usp:jan]
77. Sodium 5,5-diphenylhydantoin
78. Diphenylhydantoin, Sodium Salt
79. Sodium 5,5-diphenyl-2,4-imidazolidinedione
80. Unii-4182431bjh
81. Hydantoin, 5,5-diphenyl-, Monosodium Salt
82. Opera_id_1233
83. Dsstox_cid_3775
84. Dsstox_rid_77190
85. Dsstox_gsid_23775
86. Spectrum1500485
87. Schembl3051683
88. Dtxsid2023775
89. Phenytoin Sodium [vandf]
90. Hms501j09
91. 5,5-diphenylhydatoin Sodium Salt
92. Phenytoin Sodium [mart.]
93. Phenytoin Sodium [usp-rs]
94. Phenytoin Sodium [who-dd]
95. Phenytoin Sodium [who-ip]
96. Hms1920h10
97. Hms2091p14
98. Hms2233k24
99. Hms3259h11
100. Hms3373o11
101. Phenytoin Sodium Salt [mi]
102. Tox21_302338
103. Ccg-39219
104. Akos003273947
105. Akos015951389
106. Akos025310163
107. Phenytoin Sodium [ep Impurity]
108. Phenytoin Sodium [orange Book]
109. Nc00642
110. Nsc 757274
111. Phenytoin Sodium [ep Monograph]
112. 5,5-diphenylhydantoin Sodium Sigmaultra
113. Phenytoin Sodium [usp Monograph]
114. Ncgc00094758-01
115. Ncgc00094758-02
116. Ncgc00164434-01
117. Ncgc00255285-01
118. As-13308
119. Cas-630-93-3
120. 5,5-diphenylhydantoin Sodium Salt, >=99%
121. Phenytoinum Natricum [who-ip Latin]
122. D1331
123. Diphenylhydantoin Sodium [green Book]
124. Phenytoin Sodium For Injection [jan]
125. En300-49847
126. H12023
127. A834211
128. Sr-05000001698
129. Q-201564
130. Sr-05000001698-1
131. Q27258415
132. 2,4-imidazolidinedione, 5,5-diphenyl-, Sodium Salt (1:1)
133. Phenytoin Sodium, European Pharmacopoeia (ep) Reference Standard
134. Phenytoin Sodium, United States Pharmacopeia (usp) Reference Standard
135. Phenytoin Sodium, Pharmaceutical Secondary Standard; Certified Reference Material
1. Phenylhydantoin
Molecular Weight | 274.25 g/mol |
---|---|
Molecular Formula | C15H11N2NaO2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 2 |
Exact Mass | 274.07182188 g/mol |
Monoisotopic Mass | 274.07182188 g/mol |
Topological Polar Surface Area | 47.2 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 356 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Phenytoin sodium |
Drug Label | Phenytoin sodium is an antiepileptic drug. Phenytoin sodium is related to the barbiturates in chemical structure, but has a five-membered ring. The chemical name is sodium 5,5-diphenyl-2, 4-imidazolidinedione, having the following structural formula:... |
Active Ingredient | Phenytoin sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | 50mg/ml |
Market Status | Prescription |
Company | Hospira; Hikma Maple; X-gen Pharms; Luitpold |
2 of 2 | |
---|---|
Drug Name | Phenytoin sodium |
Drug Label | Phenytoin sodium is an antiepileptic drug. Phenytoin sodium is related to the barbiturates in chemical structure, but has a five-membered ring. The chemical name is sodium 5,5-diphenyl-2, 4-imidazolidinedione, having the following structural formula:... |
Active Ingredient | Phenytoin sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | 50mg/ml |
Market Status | Prescription |
Company | Hospira; Hikma Maple; X-gen Pharms; Luitpold |
Anticonvulsants
Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)
Cytochrome P-450 CYP1A2 Inducers
Drugs and compounds that induce the synthesis of CYTOCHROME P-450 CYP1A2. (See all compounds classified as Cytochrome P-450 CYP1A2 Inducers.)
Voltage-Gated Sodium Channel Blockers
A class of drugs that inhibit the activation of VOLTAGE-GATED SODIUM CHANNELS. (See all compounds classified as Voltage-Gated Sodium Channel Blockers.)
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20433
Submission : 2007-03-25
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-05-31
Pay. Date : 2018-03-27
DMF Number : 32676
Submission : 2018-03-29
Status : Active
Type : II
Date of Issue : 2022-06-17
Valid Till : 2025-07-21
Written Confirmation Number : WC-0062
Address of the Firm :
NDC Package Code : 53747-082
Start Marketing Date : 2018-03-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4531
Submission : 1982-04-07
Status : Active
Type : II
NDC Package Code : 12711-4466
Start Marketing Date : 1969-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
GDUFA
DMF Review : Reviewed
Rev. Date : 2024-10-18
Pay. Date : 2024-10-15
DMF Number : 4538
Submission : 1982-04-07
Status : Active
Type : II
NDC Package Code : 12711-4466
Start Marketing Date : 1969-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16301
Submission : 2002-12-05
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7304
Submission : 1988-01-22
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7229
Submission : 1987-11-20
Status : Inactive
Type : II
NDC Package Code : 0009-0087
Start Marketing Date : 2013-12-13
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?